140 related articles for article (PubMed ID: 17655586)
1. Detection of misfolded prion protein in blood with conformationally sensitive peptides.
Pan T; Sethi J; Nelsen C; Rudolph A; Cervenakova L; Brown P; Orser CS
Transfusion; 2007 Aug; 47(8):1418-25. PubMed ID: 17655586
[TBL] [Abstract][Full Text] [Related]
2. Rapid presymptomatic detection of PrPSc via conformationally responsive palindromic PrP peptides.
Grosset A; Moskowitz K; Nelsen C; Pan T; Davidson E; Orser CS
Peptides; 2005 Nov; 26(11):2193-200. PubMed ID: 16269350
[TBL] [Abstract][Full Text] [Related]
3. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
4. A sensitive and quantitative assay for normal PrP in plasma.
Gregori L; Gray BN; Rose E; Spinner DS; Kascsak RJ; Rohwer RG
J Virol Methods; 2008 May; 149(2):251-9. PubMed ID: 18339433
[TBL] [Abstract][Full Text] [Related]
5. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?
Purdey M
Med Hypotheses; 2000 Feb; 54(2):278-306. PubMed ID: 10790765
[TBL] [Abstract][Full Text] [Related]
6. PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.
Herzog C; Rivière J; Lescoutra-Etchegaray N; Charbonnier A; Leblanc V; Salès N; Deslys JP; Lasmézas CI
J Virol; 2005 Nov; 79(22):14339-45. PubMed ID: 16254368
[TBL] [Abstract][Full Text] [Related]
7. Blood infectivity, processing and screening tests in transmissible spongiform encephalopathy.
Brown P
Vox Sang; 2005 Aug; 89(2):63-70. PubMed ID: 16101685
[TBL] [Abstract][Full Text] [Related]
8. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
[TBL] [Abstract][Full Text] [Related]
9. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy.
Trieschmann L; Navarrete Santos A; Kaschig K; Torkler S; Maas E; Schätzl H; Böhm G
BMC Biotechnol; 2005 Oct; 5():26. PubMed ID: 16202155
[TBL] [Abstract][Full Text] [Related]
10. Detection of prion protein using a capillary electrophoresis-based competitive immunoassay with laser-induced fluorescence detection and cyclodextrin-aided separation.
Yang WC; Yeung ES; Schmerr MJ
Electrophoresis; 2005 May; 26(9):1751-9. PubMed ID: 15815999
[TBL] [Abstract][Full Text] [Related]
11. An overview of the diagnostic tools.
Coste J
Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
[TBL] [Abstract][Full Text] [Related]
12. Are prions transported by plasma exosomes?
Cervenakova L; Saá P; Yakovleva O; Vasilyeva I; de Castro J; Brown P; Dodd R
Transfus Apher Sci; 2016 Aug; 55(1):70-83. PubMed ID: 27499183
[TBL] [Abstract][Full Text] [Related]
13. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
[TBL] [Abstract][Full Text] [Related]
14. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
Bastian FO; Fermin CD
Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
[TBL] [Abstract][Full Text] [Related]
15. Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease.
Cervenakova L; Brown P; Soukharev S; Yakovleva O; Diringer H; Saenko EL; Drohan WN
Electrophoresis; 2003 Mar; 24(5):853-9. PubMed ID: 12627447
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
17. TSE clearance during plasma products separation process by Gradiflow(TM).
Wang K; Johnson A; Obradovic M; Anderson G; Maclean C; Nair H
Biologicals; 2005 Jun; 33(2):87-94. PubMed ID: 15939286
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of a screening assay that identifies the abnormal prion protein PrPTSE in plasma: initial results with 20,000 samples.
Guntz P; Walter C; Schosseler P; Morel P; Coste J; Cazenave JP
Transfusion; 2010 May; 50(5):989-95. PubMed ID: 20088835
[TBL] [Abstract][Full Text] [Related]
19. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry.
Kim JI; Wang C; Kuizon S; Xu J; Barengolts D; Gray PC; Rubenstein R
J Neuroimmunol; 2005 Jan; 158(1-2):112-9. PubMed ID: 15589044
[TBL] [Abstract][Full Text] [Related]
20. Current and future molecular diagnostics for prion diseases.
Lehto MT; Peery HE; Cashman NR
Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
